Cui Zhiping
Vice President and General Manager of VC Investment Department @ Fosun Pharma
Cui Zhiping is a seed investor at Fosun Pharma focused on Health Care and Medical. Cui Zhiping is Vice President and General Manager of VC Investment Department of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.. He was born in April 1963 and holds a master’s degree. From 2001 to 2005, he served for Shanghai Pharmaceutical Co., Ltd.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Cui Zhiping invests in
Stages Cui Zhiping invests in
Countries Cui Zhiping invests in
Investment Focus
Industry
- Health Care 2 (67%)
- Medical 1 (33%)
- Therapeutics 1 (33%)
- Medical Device 1 (33%)
- Pharmaceutical 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Xingaotopi
|
Xingaotopi focuses on the innovative development of novel therapeutic drugs for sensorineural hearing loss, aiming to restore auditory function and improve quality of life through advanced biomedical research and cutting-edge treatment technologies. | $14.3M / Seed / Jan 04, 2026 | |
Conjustar
|
Conjustar, a protein-conjugated medicine developer that has rapidly built a robust R&D pipeline through a combination of introduction and independent research and development. it delivers more effective and safer new cancer therapy options to the majority of cancer patients. | $13.6M / Seed / Jan 16, 2025 | |
|
Conjustar
|
Conjustar, a protein-conjugated medicine developer that has rapidly built a robust R&D pipeline through a combination of introduction and independent research and development. it delivers more effective and safer new cancer therapy options to the majority of cancer patients. | $12.7M / Seed / Jan 30, 2024 |
Co-Investors
About Fosun Pharma
Fosun Pharma is a biopharmaceutical and healthcare industry. Fosun Pharma has captured opportunities within the rapidly developing Chinese healthcare industry as well as from the globalization of Chinese healthcare companies in general. Fosun Pharma's operations strategically cover several important segments of the healthcare industryvalue-chain, including: pharmaceutical manufacturing, distribution and retail.
Fosun Pharma Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Cui Zhiping
Vice President and General Manager of VC Investment Department
|
|||
Hongfei Jia
SVP, Joint Chief Investment Officer and General Manager of International Operations Department
|
|||
Wai Danny
Independent Non-Executive Director
|
|||
Wu Yifang
Senior vice president and Chief operating officer
|
|||
Zhou Biao
SVP, General Manager of Legal Department and General Manager of Independent Inspectors Department
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Cui Zhiping invest in?
Cui Zhiping invests primarily in Health Care, Medical and Therapeutics startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Cui Zhiping last invest?
The most recent investment recorded for Cui Zhiping closed in Jan 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
